Regeneron Study Site

Centennial, Colorado

Use our guide to learn which trials are right for you!

We've found
3 trials
at this facility
Atopic Dermatitis Clinical Trial
Open Label, Drug-Drug Interaction (DDI) Study of Dupilumab (REGN668/SAR231893) in Patients With Moderate to Severe Atopic Dermatitis (AD)
Status: Enrolling, Phase I
Updated: 1/4/2016
Regeneron Study Site
mi
from
Centennial, CO
Click here to add this to my saved trials
Atopic Dermatitis Clinical Trial
Study to Assess the Long-term Safety of Dupilumab Administered in Participants ≥6 Months to
Status: Enrolling, Phase III
Updated: 12/31/1969
Regeneron Study Site
mi
from
Centennial, CO
Click here to add this to my saved trials
Dermatitis, Atopic Clinical Trial
Safety, Pharmacokinetics and Efficacy of Dupilumab in Patients ≥6 Months to
Status: Enrolling, Phase II, III
Updated: 12/31/1969
Regeneron Study Site
mi
from
Centennial, CO
Click here to add this to my saved trials